Journal rankings · indicator year 2014
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2014
Rheumatology journal rankings 2014
59 ranked journals · Subfield in Medicine
Rheumatology has 59 ranked journals in 2014. The median OJR fell 0.07 on 2013 to 0.88, below the world average of 1.00; Q1 starts at OJR 1.73. The top three are Annals of the Rheumatic Diseases, Arthritis & Rheumatism, and Autoimmunity Reviews.
Ranks and citation indicators: 2014. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2011–2013, the window the 2014 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery734
- Pulmonary and Respiratory Medicine283
- Public Health, Environmental and Occupational Health244
- Cardiology and Cardiovascular Medicine227
- Oncology179
- Infectious Diseases173
- Epidemiology166
- Neurology138
- Endocrinology, Diabetes and Metabolism136
- Radiology, Nuclear Medicine and Imaging136
- Physiology127
- Psychiatry and Mental health119
- Rheumatology59
Show all 42 subfields
- Orthopedics and Sports Medicine89
- Pediatrics, Perinatology and Child Health80
- Ophthalmology75
- Dermatology74
- Hematology69
- Obstetrics and Gynecology58
- Nephrology51
- Pharmacology43
- Reproductive Medicine43
- Complementary and alternative medicine41
- Emergency Medicine36
- Geriatrics and Gerontology35
- Otorhinolaryngology34
- Rehabilitation25
- Critical Care and Intensive Care Medicine22
- Pathology and Forensic Medicine21
- Genetics19
- Hepatology18
- Immunology and Allergy16
- Anesthesiology and Pain Medicine12
- Urology12
- Gastroenterology6
- Internal Medicine5
- Transplantation3
- Family Practice2
- Health Informatics1
- Anatomy0
- Biochemistry0
- Microbiology0
59 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2013. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2011–2013, the window the 2014 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2011–2013 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2005 to 2014. | Compare |
|---|---|---|---|---|---|---|---|
1Annals of the Rheumatic DiseasesBMJ · United Kingdom | 3.45Q1 | 7.95 0.43 down from 2013 | 1,487 | 7% | $4,870 | ||
2Arthritis & RheumatismWiley · United States | 3.35Q1 | 8.36 0.60 up from 2013 | 1,238 | 0% | — | ||
3Autoimmunity ReviewsElsevier BV · Netherlands | 3.07Q1 | 9.24 1.52 up from 2013 | 428 | 13% | $4,730 | ||
4Current Opinion in RheumatologyLippincott Williams & Wilkins · United States | 2.94Q1 | 5.96 0.57 down from 2013 | 287 | 26% | — | ||
5Best Practice & Research Clinical RheumatologyElsevier BV · Netherlands | 2.74Q1 | 4.80 0.02 up from 2013 | 187 | 14% | $4,180 | ||
6European Cells and MaterialsOASwitzerland | 2.73Q1 | 6.22 0.01 up from 2013 | 184 | 100% | $1,000 | ||
7Arthritis Care & ResearchWiley · United States | 2.65Q1 | 5.46 0.23 down from 2013 | 876 | 43% | $4,640 | ||
8Arthritis & RheumatologyWiley · United States | 2.34Q1 | 4.73no 2013 value | 116 | 33% | $5,190 | — | |
9Osteoarthritis and CartilageElsevier BV · United Kingdom | 2.06Q1 | 4.79 0.49 down from 2013 | 662 | 100% | $3,700 | ||
10Current Rheumatology ReportsSpringer Science+Business Media · United States | 1.92Q1 | 4.01 0.22 down from 2013 | 237 | 29% | $4,490 | ||
11International Journal of RheumatologyHindawi Publishing Corporation · United Kingdom | 1.86Q1 | 4.67 0.53 up from 2013 | 103 | 100% | $950 | ||
12Therapeutic Advances in Musculoskeletal DiseaseOASAGE Publishing · United Kingdom | 1.86Q1 | 4.98 1.81 up from 2013 | 85 | 100% | $2,650 | ||
13Lara D. VeekenOxford University Press · United Kingdom | 1.81Q1 | 4.08 0.12 down from 2013 | 1,120 | 29% | $4,597 | ||
14Rheumatic Disease Clinics of North AmericaElsevier BV · United States | 1.75Q1 | 3.99 1.07 up from 2013 | 137 | 22% | $3,500 | ||
15Arthritis Research & TherapyOABioMed Central · United Kingdom | 1.73Q1 | 3.39 0.54 down from 2013 | 1,130 | 100% | $3,690 | ||
16Seminars in Arthritis and RheumatismElsevier BV · United States | 1.62Q2 | 4.38 0.68 down from 2013 | 271 | 25% | $4,370 | ||
17ArthritisHindawi Publishing Corporation · United Kingdom | 1.52Q2 | 3.16 0.31 down from 2013 | 69 | 78% | — | ||
18LupusSAGE Publishing · United Kingdom | 1.38Q2 | 3.17 0.14 up from 2013 | 677 | 17% | $4,150 | ||
19The Journal of RheumatologyThe Journal of Rheumatology Publishing Company Limited · Canada | 1.35Q2 | 2.78 0.38 down from 2013 | 1,285 | 97% | — | ||
20Autoimmune DiseasesOAHindawi Publishing Corporation · United Kingdom | 1.26Q2 | 3.28 0.38 down from 2013 | 120 | 100% | $950 | ||
21The Open Rheumatology JournalOABentham Science Publishers · Netherlands | 1.22Q2 | 3.23 0.74 up from 2013 | 90 | 100% | — | ||
22Clinical Medicine Insights Arthritis and Musculoskeletal DisordersOASAGE Publishing · United Kingdom | 1.18Q2 | 2.62 0.14 up from 2013 | 31 | 100% | $4,150 | ||
23Expert Review of Clinical ImmunologyTaylor & Francis · United Kingdom | 1.13Q2 | 2.57 0.49 down from 2013 | 312 | 34% | — | ||
24Clinical RheumatologySpringer Science+Business Media · Belgium | 1.06Q2 | 2.23 0.16 down from 2013 | 793 | 18% | $4,890 | ||
25Joint Bone SpineElsevier BV · France | 1.01Q2 | 2.35 0.04 down from 2013 | 516 | 6% | $3,020 | ||
26Scandinavian Journal of RheumatologyTaylor & Francis · United Kingdom | 1.00Q2 | 2.24 0.06 down from 2013 | 298 | 17% | — | ||
27International Urogynecology JournalSpringer Science+Business Media · United Kingdom | 0.92Q2 | 2.12 0.08 up from 2013 | 871 | 26% | $3,790 | ||
28Nature Reviews RheumatologyNature Portfolio · United Kingdom | 0.90Q2 | 3.80 0.23 up from 2013 | 686 | 13% | — | ||
29Modern RheumatologyOxford University Press · United States | 0.90Q2 | 2.11no change | 1,056 | 10% | $3,208 | ||
30Connective Tissue ResearchTaylor & Francis · United Kingdom | 0.88Q2 | 1.89 0.29 down from 2013 | 151 | 48% | — | ||
31ISRN RheumatologyOAHindawi Publishing Corporation · Egypt | 0.82Q3 | 1.96 0.37 up from 2013 | 45 | 100% | — | ||
32CartilageSAGE Publishing · United States | 0.82Q3 | 0.99 0.68 down from 2013 | 117 | 100% | $2,650 | ||
33International Journal of Rheumatic DiseasesWiley · Australia | 0.81Q3 | 1.25 0.55 down from 2013 | 432 | 25% | $3,700 | ||
34Musculoskeletal CareWiley · United Kingdom | 0.80Q3 | 1.60 0.05 down from 2013 | 88 | 24% | $3,240 | ||
35UrogynecologyLippincott Williams & Wilkins · United States | 0.79Q3 | 1.52 0.18 up from 2013 | 240 | 19% | — | ||
36Rheumatology InternationalSpringer Science+Business Media · Germany | 0.78Q3 | 1.75 0.11 up from 2013 | 1,195 | 17% | $4,990 | ||
| 0.77Q3 | 3.16 0.66 up from 2013 | 72 | 92% | — | |||
38JCR Journal of Clinical RheumatologyLippincott Williams & Wilkins · United States | 0.70Q3 | 1.26 0.20 down from 2013 | 418 | 13% | — | ||
39Revista Brasileira de ReumatologiaOAElsevier BV · Brazil | 0.58Q3 | 1.33 0.03 down from 2013 | 227 | 100% | $2,490 | ||
40Case Reports in RheumatologyOAHindawi Publishing Corporation · United Kingdom | 0.45Q3 | 0.96 0.14 up from 2013 | 85 | 100% | $790 | ||
41Revista Brasileira de Reumatologia (English Edition)Elsevier BV · Spain | 0.41Q3 | 0.86no 2013 value | 73 | 100% | — | — | |
42Reumatología ClínicaElsevier BV · Spain | 0.37Q3 | 0.88 0.03 up from 2013 | 351 | 8% | $3,180 | ||
43Open Access Rheumatology Research and ReviewsOADove Medical Press · New Zealand | 0.36Q3 | 0.91 0.39 up from 2013 | 30 | 100% | $2,320 | ||
44Reumatología Clínica (English Edition)Elsevier BV · Spain | 0.34Q3 | 0.84 0.21 up from 2013 | 280 | 0% | $3,170 | ||
45Autoimmunity HighlightsOASpringer Science+Business Media · Italy | 0.29Q3 | 0.89 0.03 up from 2013 | 38 | 100% | $1,990 | ||
46International Journal of Clinical RheumatologyOAOMICS Publishing Group · United Kingdom | 0.29Q4 | 0.54 0.14 down from 2013 | 208 | 7% | — | ||
47Alexandria Journal of MedicineOAElsevier BV | 0.28Q4 | 0.57 0.12 up from 2013 | 185 | 99% | $750 | ||
48Zeitschrift für RheumatologieSpringer Science+Business Media · Germany | 0.27Q4 | 0.64 0.03 down from 2013 | 323 | 14% | $3,390 | ||
49ReumatismoOAPAGEPress (Italy) · Italy | 0.26Q4 | 1.23 0.59 up from 2013 | 576 | 100% | — | ||
50Rheumatology ReportsOAPAGEPress (Italy) · Italy | 0.24Q4 | 0.50 0.12 up from 2013 | 31 | 100% | — |
Subfields of Medicine, with Rheumatology highlighted.
- Surgery734
- Pulmonary and Respiratory Medicine283
- Public Health, Environmental and Occupational Health244
- Cardiology and Cardiovascular Medicine227
- Oncology179
- Infectious Diseases173
- Epidemiology166
- Neurology138
- Endocrinology, Diabetes and Metabolism136
- Radiology, Nuclear Medicine and Imaging136
- Physiology127
- Psychiatry and Mental health119
- Orthopedics and Sports Medicine89
- Pediatrics, Perinatology and Child Health80
- Ophthalmology75
- Dermatology74
- Hematology69
- Rheumatology59
- Obstetrics and Gynecology58
- Nephrology51
- Pharmacology43
- Reproductive Medicine43
- Complementary and alternative medicine41
- Emergency Medicine36
- Geriatrics and Gerontology35
- Otorhinolaryngology34
- Rehabilitation25
- Critical Care and Intensive Care Medicine22
- Pathology and Forensic Medicine21
- Genetics19
- Hepatology18
- Immunology and Allergy16
- Anesthesiology and Pain Medicine12
- Urology12
- Gastroenterology6
- Internal Medicine5
- Transplantation3
- Family Practice2
- Health Informatics1
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2014. Corpus-wide, 77.7% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
13 additional Rheumatology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2011–2013, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2014. Publication window: 2011–2013. How these summaries are calculated
- Ranked journals
- 59
- Window papers (baseline)
- 51,214 +11.1% from indicator year 2011
- Median OJR
- 0.879 -1.0% from indicator year 2011
- Rising journals (2025)
- 6
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2011–2013 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 20 | 24 | 25 | 27 | 30 | 32 | 37 | 38 | 38 | 39 | 43 | 49 | 53 | 56 | 59 | 58 | 58 | 65 | 65 | 67 | 69 | 67 | 65 | 67 | 67 | 70 | |
| Window papers (baseline) | 17,821 | 20,685 | 22,377 | 24,459 | 25,269 | 27,867 | 30,643 | 33,672 | 36,348 | 39,439 | 42,988 | 46,086 | 48,179 | 49,400 | 51,214 | 53,341 | 54,578 | 55,366 | 56,123 | 57,306 | 59,410 | 62,541 | 65,720 | 67,501 | 67,701 | 69,555 | |
| Median OJR | 0.91 | 0.782 | 0.862 | 0.81 | 0.884 | 1.05 | 0.855 | 0.803 | 0.92 | 0.891 | 0.7969 | 0.888 | 0.877 | 0.95 | 0.879 | 0.847 | 0.9574 | 0.889 | 0.873 | 0.93 | 0.99 | 0.9569 | 0.869 | 0.851 | 0.785 | 0.7970 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.